The Central Role of pH in the Clinical Pharmacology of Nicotine: Implications for Abuse Liability, Cigarette Harm Reduction and FDA Regulation
Neal L. Benowitz
Abstract
Dr. Benowitz has been a consultant to Pfizer and Achieve Life Sciences, companies that market or are developing smoking cessation medications, and has been a paid expert witness in litigation against tobacco companies.
Topics & Concepts
Abuse liabilityNicotineHarm reductionClinical pharmacologyHarmCriminal liabilityPharmacologyMedicineLiabilityWitnessFood and drug administrationBusinessDrugPsychiatryCriminologyPsychologyLawFamily medicinePolitical scienceAccountingCriminal lawHuman immunodeficiency virus (HIV)Smoking Behavior and CessationConsumer Attitudes and Food LabelingNicotinic Acetylcholine Receptors Study